525 related articles for article (PubMed ID: 12750397)
1. Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.
Braz JC; Bueno OF; Liang Q; Wilkins BJ; Dai YS; Parsons S; Braunwart J; Glascock BJ; Klevitsky R; Kimball TF; Hewett TE; Molkentin JD
J Clin Invest; 2003 May; 111(10):1475-86. PubMed ID: 12750397
[TBL] [Abstract][Full Text] [Related]
2. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
[TBL] [Abstract][Full Text] [Related]
3. c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling.
Liang Q; Bueno OF; Wilkins BJ; Kuan CY; Xia Y; Molkentin JD
EMBO J; 2003 Oct; 22(19):5079-89. PubMed ID: 14517246
[TBL] [Abstract][Full Text] [Related]
4. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs.
Molkentin JD
Cardiovasc Res; 2004 Aug; 63(3):467-75. PubMed ID: 15276472
[TBL] [Abstract][Full Text] [Related]
5. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
[TBL] [Abstract][Full Text] [Related]
6. Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-kappaB.
Tsatsanis C; Patriotis C; Tsichlis PN
Oncogene; 1998 Nov; 17(20):2609-18. PubMed ID: 9840924
[TBL] [Abstract][Full Text] [Related]
7. Negative feedback regulation of MKK6 mRNA stability by p38alpha mitogen-activated protein kinase.
Ambrosino C; Mace G; Galban S; Fritsch C; Vintersten K; Black E; Gorospe M; Nebreda AR
Mol Cell Biol; 2003 Jan; 23(1):370-81. PubMed ID: 12482988
[TBL] [Abstract][Full Text] [Related]
8. MAP kinase kinase 6-p38 MAP kinase signaling cascade regulates cyclooxygenase-2 expression in cardiac myocytes in vitro and in vivo.
Degousee N; Martindale J; Stefanski E; Cieslak M; Lindsay TF; Fish JE; Marsden PA; Thuerauf DJ; Glembotski CC; Rubin BB
Circ Res; 2003 Apr; 92(7):757-64. PubMed ID: 12649265
[TBL] [Abstract][Full Text] [Related]
9. The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy.
Liao P; Georgakopoulos D; Kovacs A; Zheng M; Lerner D; Pu H; Saffitz J; Chien K; Xiao RP; Kass DA; Wang Y
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12283-8. PubMed ID: 11593045
[TBL] [Abstract][Full Text] [Related]
10. Heme oxygenase-1 inhibition of MAP kinases, calcineurin/NFAT signaling, and hypertrophy in cardiac myocytes.
Tongers J; Fiedler B; König D; Kempf T; Klein G; Heineke J; Kraft T; Gambaryan S; Lohmann SM; Drexler H; Wollert KC
Cardiovasc Res; 2004 Aug; 63(3):545-52. PubMed ID: 15276480
[TBL] [Abstract][Full Text] [Related]
11. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.
Passier R; Zeng H; Frey N; Naya FJ; Nicol RL; McKinsey TA; Overbeek P; Richardson JA; Grant SR; Olson EN
J Clin Invest; 2000 May; 105(10):1395-406. PubMed ID: 10811847
[TBL] [Abstract][Full Text] [Related]
12. Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes.
Fiedler B; Wollert KC
Cardiovasc Res; 2004 Aug; 63(3):450-7. PubMed ID: 15276470
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of DYRK1A in cardiomyocytes inhibits acute NFAT activation but does not prevent hypertrophy in vivo.
Grebe C; Klingebiel TM; Grau SP; Toischer K; Didié M; Jacobshagen C; Dullin C; Hasenfuss G; Seidler T
Cardiovasc Res; 2011 Jun; 90(3):521-8. PubMed ID: 21273244
[TBL] [Abstract][Full Text] [Related]
14. Role of 14-3-3-mediated p38 mitogen-activated protein kinase inhibition in cardiac myocyte survival.
Zhang S; Ren J; Zhang CE; Treskov I; Wang Y; Muslin AJ
Circ Res; 2003 Nov; 93(11):1026-8. PubMed ID: 14593000
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II induces myocyte enhancer factor 2- and calcineurin/nuclear factor of activated T cell-dependent transcriptional activation in vascular myocytes.
Suzuki E; Nishimatsu H; Satonaka H; Walsh K; Goto A; Omata M; Fujita T; Nagai R; Hirata Y
Circ Res; 2002 May; 90(9):1004-11. PubMed ID: 12016267
[TBL] [Abstract][Full Text] [Related]
16. Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo.
Antos CL; McKinsey TA; Frey N; Kutschke W; McAnally J; Shelton JM; Richardson JA; Hill JA; Olson EN
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):907-12. PubMed ID: 11782539
[TBL] [Abstract][Full Text] [Related]
17. Ras participates in the activation of p38 MAPK by interleukin-1 by associating with IRAK, IRAK2, TRAF6, and TAK-1.
McDermott EP; O'Neill LA
J Biol Chem; 2002 Mar; 277(10):7808-15. PubMed ID: 11744690
[TBL] [Abstract][Full Text] [Related]
18. Cell-type-specific activation of p38 protein kinase cascades by the novel tumor promoter palytoxin.
Li S; Wattenberg EV
Toxicol Appl Pharmacol; 1999 Oct; 160(2):109-19. PubMed ID: 10527909
[TBL] [Abstract][Full Text] [Related]
19. The MKK6-p38 MAPK pathway prolongs the cardiac contractile calcium transient, downregulates SERCA2, and activates NF-AT.
Andrews C; Ho PD; Dillmann WH; Glembotski CC; McDonough PM
Cardiovasc Res; 2003 Jul; 59(1):46-56. PubMed ID: 12829175
[TBL] [Abstract][Full Text] [Related]
20. Regulation of gene expression by the small GTPase Rho through the ERK6 (p38 gamma) MAP kinase pathway.
Marinissen MJ; Chiariello M; Gutkind JS
Genes Dev; 2001 Mar; 15(5):535-53. PubMed ID: 11238375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
